• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750TFX26
Device Problem Material Deformation (2976)
Patient Problem Unspecified Vascular Problem (4441)
Event Date 11/08/2023
Event Type  Injury  
Event Description
As reported by an edwards canada affiliate, during a right transfemoral tavr procedure with a 26mm sapien 3 ultra valve, resistance was felt while attempting to advance the commander delivery system and valve through the iliac, so it was attempted to retract on the delivery system to change the angle of approach.However, the commander delivery system balloon started to align on the valve and resistance was felt on the system, so retraction of the system was stopped.The esheath appeared to have split on fluoro, and it was also observed that the distal end of the valve and the proximal end of the pusher were outside the esheath.The commander delivery and valve were removed as one unit with the esheath with difficulties due to the esheath split.The patient received 3 iliac stents to repair the vascular damage from the removal of the system.The patient was transferred to icu, and the procedure was aborted.During the icu stay, the patient stenosed iliac stents within hours of the stents being placed, and was sent for an emergency fem-fem bypass.The patient is currently recovering in stable condition in icu.The perceived root cause of the event was the patient tortuous and calcified vascular anatomy requiring the system to be torqued/heavily manipulated during the procedure.
 
Manufacturer Narrative
Investigation is still ongoing.
 
Manufacturer Narrative
The event reported is an anticipated in the risk management documentation for transcatheter heart valve procedures.The device was returned for evaluation, and the following was observed: two (2) struts bent outwards at the outflow side.The crimped valve appeared moved towards the working length of the inflation balloon.After valve expansion, the frame remained distorted.The leaflets were wrinkled and dehydrated due to storage condition (prolonged crimping) during the return handling process.The ifu, current risk mitigations include design and manufacturing controls, and training manuals have been reviewed, no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Images of the device was provided, and the following was observed: crimped valve appears punctured through sheath liner in procedural imagery.The patient's access vessel appears to have tortuous anatomy.The crimped valve was exposed through the esheath post procedure in post procedure imagery.In this case, the frame damage was confirmed based on evaluation of the returned device.As such, available information suggests that patient factors (calcification, tortuosity) and/or procedural factors (excessive device manipulation, withdrawal of crimped valve) may have contributed to the complaint event.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.Since no edwards product defects or labeling deficiencies were identified, no corrective or preventative action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key18378667
MDR Text Key331180681
Report Number2015691-2023-18681
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9750TFX26
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/30/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/21/2023
Supplement Dates Manufacturer Received02/27/2024
Supplement Dates FDA Received02/28/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured06/17/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age85 YR
Patient SexMale
-
-